Thrombophilia and hypofibrinolysis: Pathophysiologies of osteonecrosis

Clinical Orthopaedics and Related Research

Volumn 334, Issue , 1997, Pages 43-56

  Glueck, Charles J ^a   Freiberg, Richard ^a   Tracy, Trent ^a   Stroop, Davis ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; FIBRIN; GLUCOCORTICOID; LIPOPROTEIN A; PREDNISONE; PROTEIN C; STANOZOLOL; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ALCOHOLISM; BLOOD CLOTTING DISORDER; BONE NECROSIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FEMUR HEAD NECROSIS; FIBRINOLYSIS; GAUCHER DISEASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THROMBOPHILIA;

EID: 0031033325     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199701000-00007     Document Type: Conference Paper

References (27)

1. Amiral J, Adam M. Plassart V, Minard F, Vissac AM: Immunoassays for the Measurement of Protein S. In Goffney PJ (ed). Fibrinolysis: Current Prospect. London. John Libbey 125-128, 1988.
2. Amiral J, Boxer C, Rothchild C,Wolf M: Determination of Protein C by an Immunoenzymatic Assay. In Win I (ed). Protein C-Biochemical and Medical Aspects. Berlin. Walter de Gruyter & Co 67-69, 1983.
3. Chmielewska J. Rånby M. Wiman B. Evidence for rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 31:427-436, 1983.
4. Choi IH, Lee DY, Chung CY, Rhyu KH, Park SY: Changes in coagulation-fibrinolysis system in Legg-Perthes disease: A preliminary report. Proceedings of the Pediatric Orthopedic Society of North America 2:1, 1995.
5. Glueck CJ, Crawford A, Roy D, et al: Familial thrombophilia. hypofibrinolysis, and high lipoprotein (a): Pathophysiologic etiologies of Legg-Perthes disease. J Invest Med 43:233, 1995. Abstract.
6. Glueck CJ, Crawford A, Roy D, et al: Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg 78A:3-13, 1996.
7. Glueck CJ, Freiberg R. Glueck HI, et al: Hypofibrinolysis: A common, major cause of osteonecrosis. Am J Hematol 45:156-166, 1994.
8. Glueck CJ, Freiberg R, Glueck HI, et al: Idiopathic osteonecrosis, hypofibrinoiysis, high plasminogen activator inhibitor, high lipoprotein (a), and therapy with stanozolol. Am J Hematol 48:213-220, 1995.
9. Glueck CJ, Glueck HI, Greenfield D, et al: Protein C and S deficiency, thrombophilia, and hypofibrinoiysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 35:383-388, 1994.
10. Glueck CJ, Glueck HI, Mieczkowski L, et al: Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 69:460-465, 1993.
11. Glueck CJ, Glueck HI, Tracy T, et al: Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 42:36-29, 1993.
12. Glueck CJ, Glueck HI, Tracy T, el al: Inheritance conjointly contributing to fibrinolysis and hyperlipidemia. Metabolism 42:1410-1419, 1993.
13. Glueck CJ, Glueck HI, Welch M, el al: Familial idiopythic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor. Thromb Haemost 71:195-198, 1994.
14. Glueck CJ, McMahon RE, Bouquot JE, et al: Resistance to activated protein C. estrogens, and osteonecrosis of the jaws. J Invest Med 43:234, 1995. Abstract.
15. Glueck CJ, McMahon RE Bouquot J, et al: Pathophysiology of osteonecrosis of the jaw: Thrombophilia and hypofibrinolysis. Oral Sure Oral Med Oral Pathol 81:557-566, 1996.
16. Glueck O. McMahon RE, Boquot JE, Rabinovich B: Hypofibrinolysis and thrombophilia: Pathophysi- ological etiologies of osteonecrosis of the jaw and typical facial neuralgia. J Orofacial Pain 9:103, 1995. Abstract.
17. Gruppo R, Glueck CJ, McMahon RE, et al: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. Pathophysiology of osteonecrosis of the jaw. J Lab Clin Med 127:481-488, 1996.
18. Jones JP: Intravascular coagulation and osteonecrosis. Clin Orthop 277:41-54, 1992.
19. Mankin HJ: Nomraumatic necrosis of hone (Osteonecrosis). N Engl J Med 326:1473-1479, 1992.
20. Mont MA, Hungerford DS: Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 77A:-459-474, 1995.
21. Nilsson IM, Krook H, Sternby HH, Soderberg E, Soderstrom N: Severe thmrobotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 169:323-327, 1961.
22. Rånby M, Norrman B, Wallén P: A sensitive assay for tissue plasminogen activator. Thromb Res 27:743-749, 1982.
23. Rånby M, Sundell IB, Nilsson TK: Blood collection in strong acid citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 52:917-922, 1989.
24. Snedecor GW, Cochran WG: Statistical Methods, Ed 7. Ames, IA. Iowa State University Press 1980.
25. Sochynsky CL, Joyner KA, Ortel TI: Clinical note: A method for testing APC resistance in thrombotic patients. Am Clin Lab 13:26-27, 1994.
26. Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 300:517-522, 1994.
27. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS: Decreased fibrinolytic potential in patients with idiopathic avascular necrosis, and transient osteoporosis of the hip. Am J Hematol 44:243-248, 1993.